Rampart Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,641
| Closed | -$447K | – | 356 |
|
|
2020
Q3 | $447K | Sell |
1,641
-3,593
| -69% | -$979K | 0.28% | 85 |
|
|
2020
Q2 | $1.52M | Buy |
5,234
+1,419
| +37% | +$412K | 0.26% | 107 |
|
|
2020
Q1 | $908K | Buy |
3,815
+780
| +26% | +$186K | 0.43% | 54 |
|
|
2019
Q4 | $665K | Buy |
3,035
+121
| +4% | +$26.5K | 0.08% | 268 |
|
|
2019
Q3 | $494K | Sell |
2,914
-55
| -2% | -$9.32K | 0.06% | 309 |
|
|
2019
Q2 | $544K | Sell |
2,969
-154
| -5% | -$28.2K | 0.06% | 302 |
|
|
2019
Q1 | $574K | Buy |
3,123
+402
| +15% | +$73.9K | 0.07% | 297 |
|
|
2018
Q4 | $451K | Sell |
2,721
-3,491
| -56% | -$579K | 0.13% | 159 |
|
|
2018
Q3 | $546K | Sell |
6,212
-1,282
| -17% | -$113K | 0.24% | 104 |
|
|
2018
Q2 | $1.27M | Buy |
7,494
+741
| +11% | +$126K | 0.12% | 230 |
|
|
2018
Q1 | $1.1M | Buy |
6,753
+3,653
| +118% | +$596K | 0.11% | 236 |
|
|
2017
Q4 | $465K | Sell |
3,100
-312
| -9% | -$46.8K | 0.18% | 133 |
|
|
2017
Q3 | $519K | Buy |
3,412
+117
| +4% | +$17.8K | 0.18% | 132 |
|
|
2017
Q2 | $425K | Buy |
3,295
+2,619
| +387% | +$338K | 0.15% | 152 |
|
|
2017
Q1 | $74K | Sell |
676
-6,049
| -90% | -$662K | 0.03% | 194 |
|
|
2016
Q4 | $496K | Sell |
6,725
-22
| -0.3% | -$1.62K | 0.18% | 100 |
|
|
2016
Q3 | $588K | Buy |
+6,747
| New | +$588K | 0.22% | 88 |
|